Innosuisse
Swiss innovation agency faces conflict-of-interest questions over start-up grants
An investigation has identified potential conflicts of interest at Innosuisse, with members of the agency’s governing bodies linked to companies receiving millions of francs in public start-up funding. The findings raise questions about oversight, recusal rules and the allocation of Switzerland’s innovation subsidies.

More than CHF13 million in grants now sit at the centre of a widening credibility test for Switzerland’s innovation system. An investigation by Swiss public broadcaster RTS has identified at least 20 projects linked to companies associated, directly or indirectly, with members of Innosuisse’s governing bodies—the very institution responsible for distributing public support to start-ups and research-driven businesses.
The sums are significant. Innosuisse operates with an annual budget of roughly CHF300 million, making it one of the central engines of Switzerland’s effort to turn scientific expertise into commercial success. Its funding helps promising companies bridge the notoriously difficult gap between laboratory breakthroughs and scalable businesses.
But the investigation raises a blunt question: can the agency’s safeguards command public confidence when some decision-makers have professional links to grant recipients?
One case involves M*, a member of the Innovation Council, which selects companies for subsidies. Companies managed by M* received around CHF1 million in 2021. One was later selected for a flagship programme in 2024, making it eligible for a grant of up to CHF2.5 million.
Innosuisse insists that conflict-of-interest procedures apply. Yet the scrutiny is intensifying now, as taxpayers and start-ups examine not only whether rules were followed, but whether the system looks fair.
The Million-Franc Link Raises the Stakes
One council member’s business links have become the investigation’s most striking example. M*, an Innovation Council member, also manages several companies that received approximately CHF1 million from Innosuisse in 2021. The connection does not by itself prove wrongdoing, and the source does not allege that the grants were improperly awarded. It does, however, expose the tension at the heart of a specialist funding agency.
Innosuisse says council members are selected precisely because they possess recognised innovation records and practical knowledge of business realities. That expertise can strengthen decisions. It can also create overlapping networks in a country where universities, laboratories, investors and start-ups frequently collaborate across institutional boundaries.
The stakes rose further in 2024, when one company linked to M* entered one of Innosuisse’s flagship programmes, with potential support of up to CHF2.5 million. That figure alone exceeds the annual budgets of many early-stage Swiss ventures and underlines why grant decisions attract intense scrutiny.
Innosuisse also stresses that some support flows to research partners—such as university researchers working for the benefit of companies—rather than directly into corporate accounts. That distinction matters financially, but it does not erase the central governance question: how should public agencies manage influence when professional relationships and funding decisions overlap?